Brian C. Boursiquot
Brian C. Boursiquot publishes mostly in Cardiology and Cardiovascular Medicine, Molecular Biology and Neurology, on topics such as Atrial Fibrillation Management and Outcomes, Amyloidosis: Diagnosis, Treatment, Outcomes and Cardiac electrophysiology and arrhythmias.
- World rank
- #2,048,877 of 7,710,434 ranked researchers
- Rank in United States
- #620,257 of 1,627,098
- Works
- 31
- Citations
- 833
- Citations per work
- 26.9
What does Brian C. Boursiquot research?
Brian C. Boursiquot's work is mostly in Medicine (60%), Biochemistry, Genetics and Molecular Biology (9%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1960.5%
- Medicine1960.5%
- Everything else930.2%
- Life Sciences39.3%
- 1Cardiology and Cardiovascular Medicine41% of their works
- 2Molecular Biology9% of their works
- 3Neurology6% of their works
- 4Nephrology6% of their works
- 5Pathology and Forensic Medicine5% of their works
- 6Infectious Diseases4% of their works
Research topics
- Atrial Fibrillation Management and Outcomes
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Cardiac electrophysiology and arrhythmias
- Cardiac pacing and defibrillation studies
- Cardiovascular Disease and Adiposity
- Parathyroid Disorders and Treatments
- Long-Term Effects of COVID-19
- Heart Rate Variability and Autonomic Control
Which keywords describe Brian C. Boursiquot's research?
The keywords of their largest research topics: Anticoagulant Therapy, Atrial Fibrillation, Sudden Cardiac Death, Cardiac Amyloidosis, Transthyretin, Cardiovascular Disease, Arrhythmias and Cardiac Resynchronization Therapy.
- Heart Rate Variability
- Post-acute COVID-19 Syndrome
- phosphate
- Long-QT Syndrome
- FGF23
- Cardiac Resynchronization Therapy
- Cardiovascular Disease
- Cardiac Amyloidosis
- Atrial Fibrillation
- Anticoagulant Therapy
- Sudden Cardiac Death
- Transthyretin
- Arrhythmias
- Epicardial Fat
- Implantable Cardioverter-Defibrillator
- Perivascular Adipose Tissue
- Neurologic Manifestations
- Autonomic Nervous System
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 18 words, with their numbers
- Anticoagulant Therapy101 topic
- Atrial Fibrillation101 topic
- Sudden Cardiac Death82 topics
- Cardiac Amyloidosis71 topic
- Transthyretin71 topic
- Cardiovascular Disease62 topics
- Arrhythmias41 topic
- Cardiac Resynchronization Therapy41 topic
- Epicardial Fat41 topic
- FGF2341 topic
- Implantable Cardioverter-Defibrillator41 topic
- Long-QT Syndrome41 topic
- Perivascular Adipose Tissue41 topic
- phosphate41 topic
- Neurologic Manifestations31 topic
- Post-acute COVID-19 Syndrome31 topic
- Autonomic Nervous System21 topic
- Heart Rate Variability21 topic
Where does Brian C. Boursiquot work?
Brian C. Boursiquot's main affiliation in the publication record is Columbia University Irving Medical Center, United States.
How many publications and citations does Brian C. Boursiquot have?
OpenAlex counts 31 works and 833 citations for Brian C. Boursiquot, an h-index of 9, ranking #2,048,877 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Brian C. Boursiquot. Posts are plain text and can be reported.